Synthesis of visible-light-activated CeO2-x/BiCrO3 photocatalysts with S-scheme mechanism: Effectual performances in detoxification of various antibiotics and organic pollutants.

In today's world, the development of an efficient water treatment strategy requires a prospective approach for the production of active and stable photocatalysts. The construction of heterojunctions with different semiconductors is a promising procedure for improving photocatalytic performances. In the present research, binary CeO2-x/BiCrO3 photocatalysts were synthesized using a hydrothermal route preceded by a calcination step. The CeO2-x/BiCrO3 (15%) photocatalyst proved its unique performance of 29.3, 11.4, 11.7, and 23.0 times better than CeO2 for photodegradation of respectively tetracycline hydrochloride (TCH), metronidazole (MET), azithromycin (AZM), and cephalexin (CPN), as antibiotic pollutants, upon visible light. The effective photocatalytic ability, which was caused by the impressive suppression of charge carriers, can be understood by the developed S-scheme mechanism. Moreover, the lower resistance of CeO2-x/BiCrO3 (15%) compared to CeO2, CeO2-x, and BiCrO3 against the charges transfer was another confirmation for boosted photocatalytic performance of the CeO2-x/BiCrO3 (15%) nanocomposite. Ultimately, the boosted activity, repeated utilization for five runs, and biocompatibility confirmation of the purified solution through pinto bean cultivation exhibited that CeO2-x/BiCrO3 photocatalysts could have the promising capability for detoxification of polluted water.

Oxygen vacancy-rich CeO2 decorated with Cu3BiS3 nanoparticles: Outstanding visible-light photocatalytic performance towards tetracycline degradation.

Recently, the degradation of antibiotics has attracted a lot of attention all over the world, because the accumulation of these recalcitrant compounds in the environment, and their entry into the food chain have severely affected on human health. Herein, oxygen vacancy-rich CeO2 was decorated with Cu3BiS3 nanoparticles to fabricate Z-scheme CeO2-x/Cu3BiS3 photocatalysts with a simple procedure. Intriguingly, photocatalytic ability of CeO2-x/Cu3BiS3 (30%) nanocomposite in the detoxification of tetracycline hydrochloride, cephalexin, azithromycin, and rhodamine B was elevated 31.3, 28.2, 45.2, and 10.1-folds as much as CeO2, and 5.19, 5.97, 32.2, and 4.69-folds compared with the CeO2-x photocatalyst, respectively. The admirable activity of CeO2-x/Cu3BiS3 (30%) nanocomposite was ascribed to the production of many charge carriers, efficacious segregation and transfer of charges, and improved textural features, which were confirmed by UV-vis DRS, EIS, photocurrent density, PL, and BET analyses. In addition, the TC degradation pathway was investigated with LC-MS analysis, and also the biocompatibility of the purified solution was displayed with wheat seed cultivation. Regarding outstanding activity and facile synthesis, the CeO2-x/Cu3BiS3 (30%) photocatalyst could be utilized for wastewater treatment.

Mechanism Understanding of Li-ion Separation Using A Perovskite-Based Membrane.

Lithium ions play a crucial role in the energy storage industry. Finding suitable lithium-ion-conductive membranes is one of the important issues of energy storage studies. Hence, a perovskite-based membrane, Lithium Lanthanum Titanate (LLTO), was innovatively implemented in the presence and absence of solvents to precisely understand the mechanism of lithium ion separation. The ion-selective membrane's mechanism and the perovskite-based membrane's efficiency were investigated using Molecular Dynamic (MD) simulation. The results specified that the change in the ambient condition, pH, and temperature led to a shift in LLTO pore sizes. Based on the results, pH plays an undeniable role in facilitating lithium ion transmission through the membrane. It is noticeable that the hydrogen bond interaction between the ions and membrane led to an expanding pore size, from (1.07 Å) to (1.18-1.20 Å), successfully enriching lithium from seawater. However, this value in the absence of the solvent would have been 1.1 Å at 50 °C. It was found that increasing the temperature slightly impacted lithium extraction. The charge analysis exhibited that the trapping energies applied by the membrane to the first three ions (Li+, K+, and Na+) were more than the ions' hydration energies. Therefore, Li+, K+, and Na+ were fully dehydrated, whereas Mg2+ was partially dehydrated and could not pass through the membrane. Evaluating the membrane window diameter, and the combined effect of the three key parameters (barrier energy, hydration energy, and binding energy) illustrates that the required energy to transport Li ions through the membrane is higher than that for other monovalent cations.

Distribution of Hepatitis C Virus Genotypes in Patients with Major ß-Thalassemia in Mashhad, Northeast Iran.

BACKGROUND Hepatitis C virus (HCV) is considered to be the major cause of post-transfusion hepatitis in patients with thalassemia. We aimed to determine the HCV prevalence, genotypes, and viral load among patients with major ß-thalassemia in Mashhad, Iran. METHODS Medical records of all 550 patients with major ß-thalassemia who referred to ThalassemiaHemophilia Center of Mashhad (Sarvar Clinic) were reviewed from October to November 2011. Plasma samples of the patients were tested for the presence of anti-HCV antibodies by enzyme linked immunosorbent assay. Real-time polymerase chain reaction (PCR) was used to determine viral genotype and HCV RNA titer. RESULTS HCV antibodies were detected in 37 individuals (6.73%) including 17 men and 20 women with mean age of 25.2 ± 8.4 years. The PCR analysis was performed for 27 patients, of whom HCV RNA was detected in 17 patients (63.0%). Viral titers were investigated in 14 subjects and a high viral load more than 600000 copies/mL was observed in 6 patients (42.9%). The most prevalent genotypes were 3a (50.0%) followed by 1a (37.5%). No significant correlation was found between genotype and age, sex, serum ferritin, liver tests, and HCV RNA titer. CONCLUSION HCV infection among patients with thalassemia is more common than general population in Mashhad, northeast Iran. The dominant HCV subtype is 3a followed by 1a. These findings could help health authorities to provide preventive measures, and practitioners to choose the right protocol of treatment for the patients.

Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.

AIM: Human T lymphotropic virus type 1 (HTLV-1) infection with high prevalence in the north-east of Iran, particularly in Mashhad, can lead to adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and a variety of autoimmune diseases. The aim of the study was to examine the presence of autoimmune markers in HTLV carries. METHODS: Serum samples were obtained from blood donors in Mashhad, northeastern Iran. One hundred and five HTLV-1 positive (cases) and 104 age- and sex-matched HTLV-1 negative donors (controls) were assessed for presence of serum autoimmune markers by enzyme-linked immunosorbent assay. RESULTS: The mean ages of cases and controls were 40.8 ± 9.4 and 41.5 ± 9.3 years, respectively (P = 0.5). In the case group, 81.9% and in the control group 83.7% were male (P = 0.74). The frequency of positive antinuclear antibodies and anticyclic citrullinated peptide antibodies in the serum of the two groups were not significantly different (P = 0.68 and P = 0.62, respectively). Only one antineutrophil cytoplasmic antibody-positive case (1%) was observed in the group and no anti-phospholipid immunoglobulin G positivity was observed. The frequency of rheumatoid factor (RF) was greater in case group than in the control group, although the difference was not significant (P = 0.08). The amount of RF in all 12 RF positive sera were higher than normal levels (33-37 IU/mL). CONCLUSION: Because we failed to detect any significant relation between serum autoimmune markers and HTLV-1 infection, and because of the relatively low prevalence of autoimmune diseases, it could be concluded that healthy HTLV-1 carriers do not produce rheumatologic-related auto-antibodies more than the healthy population.